Altrius Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.63M | Sell |
224,859
-960
| -0.4% | -$36.9K | 2.02% | 14 |
|
|
2025
Q1 | $8.75M | Buy |
225,819
+9,819
| +5% | +$380K | 2.13% | 8 |
|
|
2024
Q4 | $7.31M | Buy |
216,000
+17,578
| +9% | +$594K | 1.96% | 13 |
|
|
2024
Q3 | $8.11M | Buy |
198,422
+229
| +0.1% | +$9.36K | 2.03% | 13 |
|
|
2024
Q2 | $7.63M | Buy |
198,193
+3,231
| +2% | +$124K | 2.01% | 14 |
|
|
2024
Q1 | $8.36M | Buy |
194,962
+13,439
| +7% | +$576K | 2.11% | 7 |
|
|
2023
Q4 | $6.73M | Buy |
181,523
+26
| +0% | +$964 | 1.87% | 14 |
|
|
2023
Q3 | $6.58M | Buy |
181,497
+1,419
| +0.8% | +$51.4K | 1.95% | 14 |
|
|
2023
Q2 | $6.42M | Buy |
180,078
+556
| +0.3% | +$19.8K | 1.9% | 16 |
|
|
2023
Q1 | $6.39M | Buy |
179,522
+5,827
| +3% | +$207K | 1.95% | 19 |
|
|
2022
Q4 | $6.1M | Buy |
173,695
+3,849
| +2% | +$135K | 1.92% | 13 |
|
|
2022
Q3 | $5M | Buy |
169,846
+85,373
| +101% | +$2.51M | 1.91% | 5 |
|
|
2022
Q2 | $4.6M | Buy |
+84,473
| New | +$4.6M | 1.49% | 18 |
|